These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 8769734)
1. Factors modifying protective effect of anti-CD18 antibodies on myocardial reperfusion injury in dogs. Perez RG; Arai M; Richardson C; DiPaula A; Siu C; Matsumoto N; Hildreth JE; Mariscalco MM; Smith CW; Becker LC Am J Physiol; 1996 Jan; 270(1 Pt 2):H53-64. PubMed ID: 8769734 [TBL] [Abstract][Full Text] [Related]
2. An anti-CD18 antibody limits infarct size and preserves left ventricular function in dogs with ischemia and 48-hour reperfusion. Arai M; Lefer DJ; So T; DiPaula A; Aversano T; Becker LC J Am Coll Cardiol; 1996 Apr; 27(5):1278-85. PubMed ID: 8609356 [TBL] [Abstract][Full Text] [Related]
3. Hydrogen peroxide pretreatment of perfused canine vessels induces ICAM-1 and CD18-dependent neutrophil adherence. Gasic AC; McGuire G; Krater S; Farhood AI; Goldstein MA; Smith CW; Entman ML; Taylor AA Circulation; 1991 Nov; 84(5):2154-66. PubMed ID: 1682068 [TBL] [Abstract][Full Text] [Related]
4. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury. Lefer DJ; Shandelya SM; Serrano CV; Becker LC; Kuppusamy P; Zweier JL Circulation; 1993 Oct; 88(4 Pt 1):1779-87. PubMed ID: 8104739 [TBL] [Abstract][Full Text] [Related]
5. Effect of anti-CD18 antibody on myocardial neutrophil accumulation and infarct size after ischemia and reperfusion in dogs. Tanaka M; Brooks SE; Richard VJ; FitzHarris GP; Stoler RC; Jennings RB; Arfors KE; Reimer KA Circulation; 1993 Feb; 87(2):526-35. PubMed ID: 8093866 [TBL] [Abstract][Full Text] [Related]
6. Administration of adenosine during reperfusion reduces injury of vascular endothelium and death of myocytes. Zhao ZQ; Nakamura M; Wang NP; Wilcox JN; Shearer S; Guyton RA; Vinten-Johansen J Coron Artery Dis; 1999 Dec; 10(8):617-28. PubMed ID: 10599541 [TBL] [Abstract][Full Text] [Related]
7. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion. Zhao ZQ; Nakamura M; Wang NP; Velez DA; Hewan-Lowe KO; Guyton RA; Vinten-Johansen J J Surg Res; 2000 Dec; 94(2):133-44. PubMed ID: 11104653 [TBL] [Abstract][Full Text] [Related]
8. Cloricromene reduces infarct size and alters postischaemic blood flow defects in dog myocardium. Groban L; Zvara DA; Deal DD; Vernon JC; Flye CW; Ma XL; Vinten-Johansen J Clin Exp Pharmacol Physiol; 1998 Jun; 25(6):417-23. PubMed ID: 9673816 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion. Budde JM; Velez DA; Zhao Z; Clark KL; Morris CD; Muraki S; Guyton RA; Vinten-Johansen J Cardiovasc Res; 2000 Aug; 47(2):294-305. PubMed ID: 10946066 [TBL] [Abstract][Full Text] [Related]
10. A chimeric IgG4 monoclonal antibody directed against CD18 reduces infarct size in a primate model of myocardial ischemia and reperfusion. Aversano T; Zhou W; Nedelman M; Nakada M; Weisman H J Am Coll Cardiol; 1995 Mar; 25(3):781-8. PubMed ID: 7860929 [TBL] [Abstract][Full Text] [Related]
11. P-selectin inhibition prevents early neutrophil activation but provides only modest protection against myocardial injury in dogs with ischemia and forty-eight hours reperfusion. Arai M; Masui Y; Goldschmidt-Clermont P; DiPaula A; Siu C; Kondo T; Becker LC J Am Coll Cardiol; 1999 Jul; 34(1):280-8. PubMed ID: 10400022 [TBL] [Abstract][Full Text] [Related]
12. CD18 integrin-dependent endothelial injury: effects of opsonized zymosan and phorbol ester activation. Lum H; Gibbs L; Lai L; Malik AB J Leukoc Biol; 1994 Jan; 55(1):58-63. PubMed ID: 7904295 [TBL] [Abstract][Full Text] [Related]
13. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Ma XL; Weyrich AS; Lefer DJ; Lefer AM Circ Res; 1993 Feb; 72(2):403-12. PubMed ID: 8418991 [TBL] [Abstract][Full Text] [Related]
14. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. Amsterdam EA; Stahl GL; Pan HL; Rendig SV; Fletcher MP; Longhurst JC Am J Physiol; 1995 Jan; 268(1 Pt 2):H448-57. PubMed ID: 7840295 [TBL] [Abstract][Full Text] [Related]
15. Complete prevention of myocardial stunning, contracture, low-reflow, and edema after heart transplantation by blocking neutrophil adhesion molecules during reperfusion. Byrne JG; Smith WJ; Murphy MP; Couper GS; Appleyard RF; Cohn LH J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1589-96. PubMed ID: 1360556 [TBL] [Abstract][Full Text] [Related]
16. Reduction of infarct size and preservation of endothelial function by multidose intravenous adenosine during extended reperfusion. Budde JM; Morris CD; Velez DA; Muraki S; Wang NP; Guyton RA; Zhao ZQ J Surg Res; 2004 Jan; 116(1):104-15. PubMed ID: 14732355 [TBL] [Abstract][Full Text] [Related]
17. Neutrophil sequestration and pulmonary dysfunction in a canine model of open heart surgery with cardiopulmonary bypass. Evidence for a CD18-dependent mechanism. Dreyer WJ; Michael LH; Millman EE; Berens KL; Geske RS Circulation; 1995 Oct; 92(8):2276-83. PubMed ID: 7554212 [TBL] [Abstract][Full Text] [Related]
18. Effects of a monoclonal antibody directed against P-selectin after myocardial ischemia and reperfusion. Lefer DJ; Flynn DM; Buda AJ Am J Physiol; 1996 Jan; 270(1 Pt 2):H88-98. PubMed ID: 8769738 [TBL] [Abstract][Full Text] [Related]
19. C5a-induced myocardial ischemia: role for CD18-dependent PMN localization and PMN-platelet interactions. Fletcher MP; Stahl GL; Longhurst JC Am J Physiol; 1993 Nov; 265(5 Pt 2):H1750-61. PubMed ID: 7902015 [TBL] [Abstract][Full Text] [Related]
20. A CD18 antibody prevents lung injury but not hypotension after intestinal ischemia-reperfusion. Hill J; Lindsay T; Valeri CR; Shepro D; Hechtman HB J Appl Physiol (1985); 1993 Feb; 74(2):659-64. PubMed ID: 8096207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]